| Biomarker ID | 1225 |
| PMID | 24167554 |
| Year | 2013 |
| Biomarker | miR-205 |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Downregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:DNA-binding transcription factor activity; DNA-binding transcription factor activity, RNA polymerase II-specific; positive regulation of cellular metabolic process; positive regulation of metabolic process; nervous system development |
| Experiment | Prostate Cancer Vs Adjacent Normal |
| Type of Biomarker | Diagnostic |
| Cohort | 40 PCa patients with Gleason (GS) 6–7 and adjacent normal regions were profiled (including the 10 in discovery set) |
| Senstivity | NA |
| Specificity | NA |
| AUC | 0.83 (95% CI: 0.74–0.91) |
| Accuracy | NA |
| Level Of Significance | p<0.0001 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | miR-205 |